Congress orders audit of cancer screening gaps in federal employee health plans
S. 1928 — Gerald E. Connolly Esophageal Cancer Awareness Act of 2025 · Filed by Mark Warner (D-VA) · 1 cosponsor · Introduced Jun 3, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Comptroller General to study esophageal cancer health care costs and screening rates among federal employees covered under the Federal Employees Health Benefits Program (FEHBP). It establishes congressional findings about the rising incidence and poor survival rates of esophageal cancer, emphasizing that early detection through screening can dramatically improve outcomes. The bill itself does not create new programs, funding, or mandates—it only requires a one-year report on current spending and screening practices.
Why we flagged it
The bill is a straightforward informational measure that directs a government audit of esophageal cancer spending and screening practices among federal employees. It contains no regulatory changes, appropriations, or mandates—only a requirement for a factual report to Congress.
What the text implies
- The report may establish a baseline for future federal policy on esophageal cancer screening, potentially leading to mandated coverage or screening protocols under FEHBP.
- Findings about low screening rates among high-risk federal employees could create political pressure for expanded preventive care coverage, affecting health insurance costs.
The full analysis lists 3 implications of this text.
Who stands to gain
diagnostic imaging and endoscopy providers; pharmaceutical companies with esophageal cancer treatments; health insurance companies (if screening reduces late-stage treatment costs)